New thrombolytic compositions
CA 2007075 C · Owner: Pharmacia & Upjohn Aktiebolag · Inventors: Mattsson, Christer; Pohl, Gunnar
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
thrombolytically active composition comprising in combination a modified tissue-type plasminogen activator (t-PA) as a major component and a normal human t-PA streptokinase or, human urokinase as a minor component in a pharmaceutically acceptable excipient;, a method of treating a thrombotic disorder; and a medicinal kit or package for use in treating thrombotic disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 3, 1990 and granted March 19, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 3, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 3, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.